Daily News: Chongqing kangkeri Pharmaceutical Co., Ltd., the sponsor of pharmaceutical intelligence elite club

Founded in 1999, Chongqing kangkeri Pharmaceutical Co., Ltd is a comprehensive enterprise integrating scientific research, production and sales, mainly producing tablets and capsules and part of APIs The enterprise has more than 20 technologies with independent intellectual property rights, and has been rated as "leading enterprise of national biological industry base" and "innovative enterprise of Chongqing", and has been recognized as a national high-tech enterprise and "double high" enterprise of high-tech products in Chongqing At present, Concord pharmaceutical has two major product dosage forms, namely tablet and capsule The production capacity of tablet can reach 1 billion tablets and capsule can reach 500 million tablets At present, the company has 25 registration documents for preparation products and 3 registration documents for raw material production, forming a series of product groups including hypoglycemic, antihypertensive, hypolipidemic, respiratory system, antibiotics, antiallergic and hepatobiliary drugs Among them, diabetes series drugs and oral disintegration preparations have become one of the most influential series drugs in China Some products have won many honors, such as "national key new products", "Chongqing excellent key new products", "high and new technology products" Over the years, the company has been committed to the path of specialization and characteristic development, with the responsibility of providing series drugs with good quality, good efficacy and high safety Some products have reached or exceeded the standards of USP and EP, among which glimepiride has been exported to foreign countries in 2007, and "liyiping" trademark has been rated as a famous trademark in Chongqing It has become a supplier of many large pharmaceutical enterprises, such as Yangzijiang pharmaceutical, Beijing Beilu pharmaceutical, southwest synthetic pharmaceutical, etc.